Ainos Announced Plan to Initiate Taiwan Clinical Study for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
<p><i><strong>Ainos Plans To Conduct the Study at National Taiwan University Hospital, a Premier Taiwanese Medical Center for HIV Management</strong></i></p><p><i><strong>The U.S. FDA Have Granted Orphan Drug...
Ainos Secures Taiwan Invention Patent and Advances Global Patent Protection for VELDONA, a Breakthrough in Coronavirus Treatment and Prevention
<p><i><strong>This patent marks a major leap in Ainos' antiviral research, contributing to global efforts against coronavirus infections</strong></i></p> Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), an...
Ainos to Participate in H.C. Wainwright 26th Annual Global Investment Conference
Company invites shareholders and all interested parties to learn our journey for ultimately becoming AI's nose capable of digitizing smell.Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the...